Konu "Safety" için Diğer Yayınlar Koleksiyonu listeleme
Toplam kayıt 3, listelenen: 1-3
-
Fingolimod for the treatment of relapsing-remitting multiple sclerosis
(Turkish Neurological Society, 2017)Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system and is characterized by inflammation, demyelination, and axonal loss. Fingolimod is the first oral drug for the treatment of MS approved ... -
Oxytocin antagonists: The next frontier in PE treatment
(Nature Publishing Group, 2019)Oxytocin antagonists seem to have potential as a treatment option for premature ejaculation (PE), but the parameters of their use are vague. Two recently published studies highlight the need for large-scale trials to ... -
An update on the drug safety of treating erectile dysfunction
(Taylor & Francis, 2019)Introduction: Treatment options for erectile dysfunction (ED) have evolved over the last two decades, particularly after the introduction of phosphodiesterase type-5 inhibitors (PDE5Is). The path, however, has not been ...